Drug intelligence / Profile preview

creatine + fluoxetine

Development stage
Unknown
Modality
Small Molecules
Administration
Oral
01

Overview

Creatine + fluoxetine is a combination of two agents—creatine, a naturally occurring compound involved in cellular energy metabolism, and fluoxetine, a selective serotonin reuptake inhibitor (SSRI) commonly used as an antidepressant. This combination has been studied primarily for its potential to enhance antidepressant effects in the treatment of depression. Preclinical studies suggest that dietary creatine supplementation may augment or accelerate the onset of antidepressant effects when combined with SSRIs like fluoxetine, particularly in females. The mechanism involves both metabolic enhancement (via creatine's role in ATP regeneration and neuroprotection) and serotonergic modulation (via fluoxetine's inhibition of serotonin reuptake). There is evidence from animal models that this combination can produce more robust antidepressant-like behavioral profiles than either agent alone[1][2][5].

02

Targets

SERT (Sodium-dependent serotonin transporter)

Beyond the preview

Go deeper on creatine + fluoxetine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on creatine + fluoxetine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call